# Intermediates for the preparation of thienamycin and process for preparing intermediates.

## Abstract
In a process for the total synthesis of thienamycin from L aspartic acid via intermediate III

## Claims
WHAT IS CLAIMED IS 1. A compound selected from the group consisting of EMI59.1 wherein R2 and R3 are independently selected from lower alkylhaving 1 6 carbon atoms, phenyl, benzyl, methoxybenzyl, or trityl R is a readily removable protecting group or hydrogen R8 is lower alkyl having 1 6 carbon atoms, or phenyl, or R2 and R3 together formEMI59.2 2. A compound according to Claim 1 , wherein R is triloweralkyl silyl having from 3 12 carbon atoms R8 is alkyl having 1 3 carbon atoms, or phenyl and R2 and R3 are EMI59.3 or alkyl having 1 3 carbon atoms each. 3. A process for preparingEMI60.1 comprising oxidizing EMI60.2 to form EMI60.3 followed by treating with R7O2CCH2CO 2 to yield EMI60.4 wherein R7 and R are readily removable protecting groups. 4. A process for preparingEMI61.1 comprising oxidizing EMI61.2 to form EMI61.3 followed by treating with R7CO2CCH2CO2 2Mg.EMI61.4 wherein R7 and R are readily removable protecting groups. 5. A compound having the structure EMI62.1 wherein R is a readily removable blocking group. 6. A compound according to Claim 5 wherein R is trialkylsilyl wherein the alkyl moieties have 1 6 carbon atoms each. 7. A compound. according to Claim 6 wherein R is t butyl dimethylsilyl. Claims for Austria 1. A process for preparingEMI63.1 comprising oxidizing EMI63.2 to form EMI63.3 followed by treating with R7O2CCH2CO 2to yield EMI63.4 wherein R7 and R are readily removable protecting groups. 2. A process for preparingEMI64.1 comprising oxidizing EMI64.2 to form EMI64.3 followed by treating with R7Co2CCH2C02 2Mg. EMI64.4 wherein R7 and R are readily removable protecting groups.

## Description
PROCESS FOR THE PREPARATION OF THIENAMYCIN AND INTERMEDIATESBACKGROUND OF THE INVENTION This invention relates to the total synthesis of the known antibiotic thienamycin I .EMI1.1 Starting from L aspartic acid, the synthesis proceeds in a stereo selective way via intermediatesII, III, IV EMI2.1 wherein X is a conventional leaving group andR is hydrogen, a conventional, readily removable protecting group or a salt cation. This invention also relates to a process for preparing III via intermediate V EMI2.2 wherein R is a protecting group. DETAILED DESCRIPTION OF THE INVENTION The process of the present invention may conveniently be summarized by the following reaction diagram DIAGRAM IEMI3.1 EMI4.1 EMI5.1 EMI6.1 In words relative t the above diagram, L aspartic acid 1 is esterified according to well known procedures. Typically 1 in a solvent such as benzene, toluene, chloroform or the like is treated with an esterifying agent such as benzyl alcohol, methanol, ethanol, ispropanol, or the like in the presence of p toluene sulfonic acid, HC1, HBr, or the like at a temperature of from 0 to 110 0C for from 1 to 24 hours to achieve the desired establishment and hence protection of the carboxyl functions.The resulting species 2 in a solvent such as ether, THF, DME or the like is treated with trimethylchlorosilane, or the like followed by treatment with EtMgBr, MeMgI, 3MgBr, t BuMgCI, or the like at a temperature of from 40 to 500C for from 1 to 72 hours to provide azetidinone 3. Reduction of species 3 with a reducing agent such as NaBH4, or the like in a solvent such as methanol, ethanol, isopropanol or the like at a temperature of from 10 to 40 C for from 1 to 6 hours provides 4. For purposes here, the symbols Et, Me, , iPr, and t Bu stand for ethyl, methyl, phenyl isopropyl, and tert butyl, respectively. Treatment of in a solvent such as methylene chloride, CHC13 or the like with methane sulfonyl chloride, methane sulfonic anhydride or the like in the presence of a base such as Et3N, iPr2NEt, or the like followed by treatment with a stoichiometric to 5 fold excess of sodium iodide in acetone yields S via The transformation 5 establishes the protecting group R which may be a triorganosilyl group, such as t butyldimethylsilyl, t butyldiphenylsilyl, triphenylsilyl, isopropyldimethylsilyl, for example,or may be 3,4 dimethoxybenzyl, for example.Silyl protection is preferred, and typically R1 is established by treating 5 in a solvent such as dimethylformamide, acetonitrile, hexamethylphosphoramide, tetrahydrofuran and the like with a silylating agent such as t butyldimethylchlorosilane, t butyldiphenylchlorosilane, triphenylchlorosilane, and the like at a temperature of from 200 to 25 C for from 0.5 to 24 hours in the presence of a base such as triethylamine, diisopropylethylamine, or imidazole. The transformation 6 7 is accomplished by treating 6 in a solvent such as tetrahydrofuran, dimethoxyethane, diethylether or the like with a carbanion generically represented by the following structure EMI8.1 wherein M is a metal cation such as lithium, potassium, copper or magnesium, for example, and R2, R3 and R4 are selected from alkyl, aryl or aralkyl such as methyl, ethyl, benzyl, methoxybenzyl, trityland phenyl, for example, at a temperature of from 100 to OOC and from 0.5 to 4 hours. Typically, the carbanion reagent is prepared prior to addition of substrate 6 on treatment of the triorganothiomethane with a strong base such as n butyllithium, t butyllithium, phenyllithium, lithium diisopropylamideOLDAL or the like. The alkylation 7 8 is accomplished by treating 7 in a solvent such as tetrahydrofuran, dimethoxyethane, diethy ether, hexamethylphosphoramide, at a temperature of from 1000 to 200C with a strong base such as lithium diisopropylamide, lithium hexamethyldisilazide, lithium 2,2,6,6 tetramethylpiperidide, potassium hydride or the like followed by the addition of an equivalent to 10 fold excess of acetaldehyde. This reaction gives a mixture of isomers from which the desired trans R form can be conveniently separated by chromatography or crystallization. The transformation 8 ,9 9 is accomplished by treating 8 in a solvent such as methanol, ethanol, isopropanol, water or the like at a temperature of from 0 to 80 C with a Lewis acid such as mercuric chloride, silver tetrafluoroborate, thallium trinitrate or the like. The value of R5 is determined by the identity of the alcohol taken in reaction. The transformation 9 , 10 establishes the hydroxyl protecting group R2. The most preferred protecting groups R2 are triorganosilyl groups such as t butyldimethylsilyl, t butyldiphenylsilyl, triphenylsilyl and the like. Typically, silylation is accomplished by treating t with the corresponding triorganosilyl chloride in a solvent such as dimethylformamide, acetonitrile,.tetrahydrofuran and the like at a temperature of from 20 to 800C for from 0.5 to 24 hours. The reduction 10 is accomplished by treating 10 in a solvent such as toluene, methylene chloride diethylether, tetrahydrofuran and the like with a reducing agent such as diisobutylaluminum hydride, sodium bis 2 methoxyethoxy aluminum hydride or the like at a temperature of from 100 to 400C for from 1 to 10 hours. The addition 11 12 is accomplished by treating 11 in a solvent such as tetrahydrofuran, diethylether, dimethoxyethane or the like at a temperature of from 1000 to 0 C for from 15 minutes two 2 hours in the presence of LiCH2CO2R6 wherein R6 is benzyl, p methoxybenzyl, 2,4 dimethoxybenzyl or the like which reagent is typically generated in situ on treatment of the appropriate R6 acetate with a strong base such as LDA, lithium hexamethyldisilazide, lithium 2,2,6,6 tetramethylpiperide, or the like. If desired, a more readily removable carboxyl protecting group may conveniently replace the first established group, R6, by the carboxyl protecting groupR7. This transformation 12 fi13 514 is accomplished by selectively deblocking 12 to form 13 by hydrogenation or hydrolysis. Typically, the reaction is accomplished by treating 12 in a solvent such as methanol, ethanol, dioxane, tetrahydrofuran, water or the like under a hydrogenation pressure of from 1 to 4 atmospheres in the presence of a catalyst such as Pd on charcoal, Pd OH 2, or the like for from 0.1 to 10 hours. The 13 intermediate M may be H, Na, K or ammonium such as Et3NH, for example need not be isolated. Intermediate 14 is obtained from the hydrogenation mixture upon treatment with the chosen reagent calculated to establish R7 such as an aralkyl halide in a solvent such as dimethylformamide, acetonitrile, hexamethylphosphoramide at a temperature of from 0 to 50 C for from 0.5 to 18 hours. R7 is typically an aralkyl group such as p nitrobenzyl, or o nitrobenzyl, for example. The oxidation 14 15 is accomplished by treating 14 in a solvent such as methylene chloride, acetonitrile, or the like with an oxidizing system such as dipyridine chromium VI oxide, 3,5 dimethylpyrazole chromium V oxide, pyridinium chlorochromate, pyridinium dichromate, trifluoroacetic anhydride dimethylsulfoxide, acetic anhydride dimethyl sulfoxide or the like at a temperature of from 780C to 250C for from 5 min. to 8 hrs. Removal of protecting groups R1 and R2 15 16 is accomplished by acidic aqueous hydrolysis of 15 in a solvent such as methanol, ethanol, tetrahydrofuran, dioxane or the like in the presence of an acid such as hydrochloric, sulfuric, acetic or the like at a temperature of from 0 to 1000C for from 2 to 18 hours. The diazo species 17 is prepared from 16 by treating 16 in a solvent such as CH3CN, CH2C12, THF or the like with an azide such as p carboxybenzene sulfonylazide, toluenesulfonylazide, methanesulfonylazide or the like in the presence of a base such as triethylamine, pyridine, C2H5 2NH or the like for from 1 to 50 hours at 0 250C.Cyclization 17 18 is accomplished by tmating 17 in a solvent such as benzene, toluene, THF or the like at a temperature of from 50 1100C for from 1 5 hours in the presence of a catalyst such as bis acetylacetonato Cu II Cu acac 2 , CUSO4, Cu powder, Rh OAc 2, or Pd OAc 2.Alternatively, the cyclization may be accomplished by irradiating 17 through a pyrex filter a wave length greater than 300nm in a solvent such as benzene,CCl4 diethylether or the like at a temperature of from 0 250C for from 0.5 to 2 hours.t OAc acetate. Establishment of leaving group X t is accomplished by acylating the keto ester 18 with an acylating agent ROX such as p toluenesulfonic acid anhydride, p nitrophenylsulfonic acid anhydride, 2,4, 6 triisopropylphenylsulfonic acid anhydride, methanesulfonic acid anhydride, toluenesulfonyl chloride, p bromophenylsulfonyl chloride, or the like whereinX is the corresponding leaving group such as toluene sulfonyloxy, p nitrophenylsulfonyloxy, methanesulfonyloxy, p bromophenylsulfonyloxy and other leaving groups which are established by conventional procedures and are well known in the art.Typically, the above acylation to establish leaving groups X is conducted in a solvent such as methylene chloride, acetonitrile or dimethylformamide, in the presence of a base such as diisopropylethylamine, triethylamine, 4 dimethylamino pyridine or the like at a temperature of from 20 to 400C for from 0.5 to 5 hours. The leaving group X of intermediate can also be halogen.The halogen leaving group is established by treating 18 with a halogenating agent such as 3PCl2, 3PBr2, O 3PBr2, oxalyl chloride or the like in a solvent such as CH2C12, CH3CN, THF, or the like in the presence of a base such as diisopropylethylamine, triethylamine, or 4 dimethylaminopyridine or the like. phenyl. The reaction 19 v20 is accomplished by treating 19 in a solvent such as dioxane, dimethylformamide, dimethylsulfoxide, acetonitrile, hexamethylphosphora mide, or the like in the presence of an approximately equivalent to excess of the mercaptan reagentHSCH2CH2NHR8 wherein R is hydrogen or a readily removableN protecting group such as p nitrobenzyloxycarbonyl, o nitrobenzyloxycarbonyl, or the like in the presence of a base such as sodium hydrogen carbonate, potassium carbonate, triethylamine, diisopropylethylamine, or the like at a temperature of from 40 to 25 C for from 1 to 72 hours.The mercaptan reagent, HSCH2CH2NHR8, is typically prepared by treating aminoethylmercaptan in the presence of the desired acid chloride in the presence of a base such as sodium bicarbonate, sodium hydroxide, or the like in a solvent such as aqueous diethylether, aqueous dioxane, aqueous acetone, or the like at a temperature of from 0 to 250C for from 0.5 to 4 hours. The final deblocking step 2 I is accomplished by conventional procedures such as hydrolysis or hydrogenation. Typically 20 in a solvent such as dioxane water ethanol, tetrahydrofuran aqueous dipotassium hydrogen phosphate isopropanol or the like is treated under a hydrogen pressure of from 1 to 4 atmospheres in the presence of a hydrogenation catalyst such as palladium on charcoal, palladium hydroxide, or the like at a temperature of from 0 to 500C for from 0.5 to 4 hours to provideI. In the above discussed aldol reaction 7 78 for introduction of the hydroxyethyl side chain, the scheme proceeds directly to give a mixture of isomers trans R, trans S, and cis R from which the desired trans R isomer can be separated chromatographically or by crystallization. An indirect aldol reaction scheme stereo selectively provides the desired trans R isomer according to the following scheme DIAGRAM IIEMI14.1 wherein all symbols are as previously defined. In words relative to the above reaction scheme,Step A has been described above. The direct acetylation, Step B,is accomplished by treating 7 with two or more equivalents of a base such as lithium diisopropylamide, lithium hexamethyldisilazide, lithium 2,2,6,6 tetramethylpiperidide, in a solvent such as tetrahydrofuran, diethylether, or dimethoxyethane, for example, at a temperature of from 100 to 20 C with an acylating agent such as N acetyl imidazole or the like. Addition of the 7 plus base mixture to the acylating agent is preferred. The oxidation Step C is accomplished with an oxidizing agent such as dipyridine chromium V oxide, trifluoroacetic anhydride,dimethylsulfoxide triethylamine, pyridinium dichromate, acetic anhydride dimethylsulfoxide in a solvent such as methylene chloride, acetonitrile, or the like at a temperature of from 78 to 25 C for from 5 minutes to 5 hours. The reduction Step D is accomplished by contacting the ketone with a reducing agent such as potassium tri sec butyl borohydride, lithium tri sec butyl borohydride, sodium borohydride, sodium tris methoxyethoxy aluminum hydride, lithium aluminum hydride or the like in a solvent such as diethylether, tetrahydrofuran, toluene or the like at a temperature of from 20 to 250C.The reaction can conveniently be conducted in the presence of an added complexing salt such as potassium iodide, magnesium bromide or the like. With reference to Diagram I, above, the present invention relates specifically to a process, and to useful intermediates encountered along the way, for proceeding from 6 to 16 according to the following scheme Diagram IIIEMI16.1 In words relative to Diagram III, all symbols are as previously defined additionally, however, R and R3 may be joined together with a bridging radical such asEMI17.1 The radical R is newly encountered in this scheme and preferably is chosen from lower alkyl, such as methyl, ethyl or aryl, such as phenyl. The transformation 6 21 is accomplished in a manner analogus to the transformation 6 o7 Diagram I except that the carbanion is generically represented by the following structure EMI17.2 wherein all symbolism, including M, is as defined above. Intermediate 21 may proceed directly to 22 in a manner exactly analogous to the transformation 73 8 Diagram I or it may take the circuitous path via 22a. The transformation 21 22a 22 is conducted in a manner exactly analogous to the scheme EMI17.3 tb 7 SEP B SEP D SEP 8 tb Diagram II . The transformationEMI17.4 is accomplished in a manner exactly analogous to the step 8 9 ofDiagram I.The oxidationEMI17.5 is preferably achieved with a 1.0 to 5.0 fold excess of an oxidizing agent such as m chloroperbenzoic acid, peracetic acid, hydrogen peroxide, pertrifluorocicetic acid, or the like, in a solvent such as chloroform, carbcntetrachloride, chlorobenzene, or the like, at a temperature of from 20C to 1300C for from 0.5 to 24 hours. S 10 15 20 25 30 The additionEMI18.1 is accomplished by treating 24 with l,l carbonyldimidazole, or the like, in a solvent such as tetrahydrofura dimethoxyethane, or the like, at a temperature of from 100 to 50 C followed by the addition of 1.1 to 3.0 equivalents of R o2CCH2CO2 2Mg, or the like, at a temperature of from 10 to 500C for from 1 to 48 hours. The deblocking of 25 to yield 16 is accomplished exactly as described for the deblockingEMI18.2 Diagram 7 . The remainder of the synthesis is exactly as described above Diagram I , picking up at 16. The synthesis described by foregoing schemes I and II Diagrams I andII and steps from 16 to thienamycin are described and claimed in co pending European PatentApplication Serial Number 79101307.1 filed May 1, 1979 this application is incorporated herein by reference. In the foregoing word description of the above schematic reaction diagram for the total synthesis of thienamycin, it is to be understood that there is considerable latitude in selection of precise reaction parameters. Suggestion of this latitude and its breadth is generally indicated by the enumeration of equivalent solvent systems, temperature ranges, protecting groups, and range of identities of involved reagents.Further, it is,to be understood that the presentation of the synthetic scheme as comprising distinct steps in a given sequence is more in the nature of a descriptive convenience than as a necessary requirement for one will recognize that the mechanically dissected scheme represents a unified scheme of synthesis and that certain steps, in actual practice, are capable of being merged, conducted simultaneously, or effected in a reverse sequence without materially altering the progress of synthesis. The following examples recite a precise scheme of total synthesis. It is to be understood that the purpose of this recitation is to further illustrate the total synthesis and not to impose any limitation. EXAMPLE 1Preparation of 4 S 4 Iodomethylazetidin 2 one STEP AEMI20.1 Benzyl S azetidin 2 one 4 carboxylate To a 1000 ml separatory funnel are added dibenzyl S aspartate rtoluenesulfonic acid salt 48.6 g, 0.1 mole , ice cold diethyl ether 300 ml , ice cold water 100 ml , and ice cold saturated aqueous potassium carbonate 50 ml . The mixture is shaken vigorously and the layers are separated. The aqueous portion is extracted with more cold diethyl ether 2 x 100 ml . The combined ether solution is washed with brine, dried with magnesium sulfate, and evaporated under vacuum to provide dibenzyl S aspartate 31.4 g, 0.1 mole as a colorless liquid The dibenzyl S aspartate in anhydrous diethyl ether 200 ml is cooled in an ice bath under a nitrogen atmosphere.Trimethylchlorosilane 12.7 ml, 0.1 mole is added to the stirred solution to give a white precipitate. Triethylamine 14.0 ml, 0.1 mole is then added to the mixture. The cooling bath is removed and the mixture is stirred at room temperature 22 250C for 2 hrs. The mixture is then filtered directly into a 3 neck, 1.0 liter, round bottom flask fitted with a sintered glass funnel, magnetic stirrer, and a vacuum nitrogen inlet. This operation is carried out under a blanket of nitrogen, care being taken to exclude atmospheric moisture.The sintered glass funnel is replayed by a stopper and the ether is evaporated under vacuum with stirring to provide dibenzyl S N trimethylsilylaspartate 35.5 g, 0.092 mole as a slightly hazy oil. Anhydrous diethyl ether 250 ml is added to the flask containing the silyl derivative and the magnetic stirrer is replaced by a mechanical stirrer. The resulting solution is stirred under a nitrogen atmosphere with ice bath cooling.Ethereal ethyl magnesium bromide 34 ml of a 294 M solution, 0.1 mole is added dropwise over 40 min.to give a cream colored, stirable precipitate.The cooling bath is removed and the mixture is stirred at room temperature. After 1.5 hrs, a viscous gum forms. The mixture is allowed to stand overnight at room temperature.The mixture is then cooled in an ice methanol bath while ammonium chloride saturated 2N hydrochloric acid 100 ml is added slowly with stirring. The resulting mixture is diluted with ethyl acetate 100 ml and water 100 ml and the layers are separated. The aqueous portion is extracted with more ethyl acetate 3 x 100 ml . The combined organic solution is washed with water 200 ml , 5 aqueous sodium bicarbonate solution 100 ml , water 100 ml , and brine, dried with magnesium sulfate, and filtered. Evaporation of the solvent under vacuum gives an orange oil interspersed with a fine, granular precipitate 25.3 g . This material is dissolved in warm chloroform 75 ml , diluted with petroleum ether 125 ml , seeded, scratched, and cooled in an ice bath.The preci pitate is collected, washed with petroleum ether, and dried under vacuum to give benzyl S azetidin2 one 4 carboxylate 3.85 g as an off white solid mp 136 139 C. The mother liquors and washings are combined, diluted with petroleum ether to 500 ml, seeded, and left in a refrigerator for several days. The resulting precipitate is collected, washed with petroleum ether, and dried under vacuum to give additional product 0.82 g as pale yellow crystals.Recrystallization of a sample from chloroform petroleum ether gave the product as small, white flakes mp 141 143 a D 43.4 c3.275 in CHCl3 IR CHC13 3425, 1778, 1746 cm Ú 1H NMR CDCl3 3.00 ddd, 1,J 1.9, 3.2, and 14.6 Hz, H 3a , 3.35 ddd, 1, J 1.5, 5.4, and 14.6 Hz, H 3b , 4.20 dd, 1, J 3.2 and 5.4 Hz, H 4 , r5.22 s, 2, OCH2Ph , 6.48 m, 1, NH , 7.38 s, 5, phenyl mass spectrum m e 205 M , 163, 91, 70, 43. Anal. Calcd. for C11H11NO3 C, 64.38 H, 5.40 N, 6.83. Found C, 64.10 H, 5.70 N, 6.77. STEP BEMI23.1 4 S 4 Hydroxymethylazetidin 2 one Sodium borohydride 3.69 g, 97.5 mmol is added in one portion to a suspension of benzyl 4 S azetidin 2 one 4 carboxylate 20.0 g, 97.5 mmol in 300 ml of absolute methanol at 0 C. The mixture is then allowed to warm slowly with periodic cooling being supplied to keep the internal temperature 300C. After stirring for 2 hr., glacial acetic acid 23.4 g, 390 mmol is added and the reaction mixture is concentrated under vacuum. The residue is treated with 500 ml of chloroform and filtered.The filtrate is concentrated under vacuum and the residue is chromatographed on 250 g of silica gel 4 1, chloroform methanol to yield 9.62 g 98 of 4 S hydroxymethylazetidin 2 one as a white solid m.p. 51 53 C alpha D 68.0 C 2.676 in CHCl3 IR CHC13 3410, 1765 cm 1H NMR CDCl3 7.07 1H, br. s, NH , 4.05 1H, br. s, OH , 3.77 2H, m H4, H 5a or b , 3.58 1H, dd, J 11, 6, H 5a or b , 2.97 1H, ddd, J 14.5, 4.8, 1.3, H3b , 2.7 1H, br. d, J 14.5,H3a mass spectrum m e 101 M , 83. STEP CEMI24.1 4 S 4 Methanesu ionyloxymethyl azetidin 2 one Metbane,isulfonyl chloride 11.46 g, 100 mmol is added dropwise by syringe to a solution of 4 S 4 hydroxymethyl azetidin 2 one 10.1 g, 100 mmol and triethyl amine 10.1 g, 100 mmol in 15 ml of dry methylene chloride at OOC. Warming is necessary in order to initially solubilize the alcohol. The resulting solution is then cooled to 0 C prior to addition of the other reagents .The resulting solution is stirred at 0 C for 1 hr. during which time a voluminous precipitate is produced. At the end of this time, the reaction mixture is filtered and the filtrate is concentrated under vacuum. The two solid residues are combined and treated with 500 ml of chloroform. The resulting mixture is filtered to yield substantially pure 4 S 4 methanesulfonyloxymethyl azetidin 2 one as a white solid. The filtrate, which contains most of the triethylamine hydrochloride, is concentrated under vacuum and chromatographed on 200 g of silica gel 4 1 chloroform methanol to yield an additional quantity of mesylate.This material is combined with that obtained previously and recrystallized from chloroform to yield 15.57 g 87 of 4 S 4methanesulfonyloxymethylazetidin 2 one as colorless needles m.p. 109.5 110.5 C alpha D 25.8 C 1.025 in H2O NMR D20 g 4.62 lH, dd, J 11.2, 3.0, H 5a or b , 4.43 1H, dd, J 11.2, 6, H 5a or b , 4.12 1H, m, H4 3.26 3H,EMI25.1 3.19 1H, dd, J 15, 4.5,H3b . 2.88 1H, dd, J 15, 2.5, H3a mass spectrum m e 179 M ,136 Anal Calc C, 33.51 H, 5.06 N, 7.82 S, 17.89 Found C, 33.54 H, 5.08 N, 7.72 S, 17.93STEP DEMI25.2 4 S 4 Iodomethylazetidin 2 one A mixture of 4 S 4 methanesulfonyloxy azetidin 2 one 11.8 g, 65.9 mmol and powdered sodium iodide 19.8 g, 132 mmol in 130 ml of acetone is heated at reflux for 6 hr. The resulting reaction mixture is concentrated in vacuo, treated with 200 ml of chloroform and filtered. The filtrate is washed with 2 X 50 ml of water and dried over magnesium sulfate. The organic phase is filtered, concentrated in vacuo, and chromatographed on 250 g of silica gel ethyl acetate to yield 11.94 g 86 of 4 S 4 iodomethyl azetidin2 one as a white solid. This material is recrystallized from ether petroleum ether to yield white crystals mp 91 920C al 23.70 C 1.354 inCHCl3 IR CHCl3 3450, D1765 cm 1, 1H NMR CHCl3 6.13 brs, N H , 3.94 m, 1 H, Hc , 3.36 m, 2H, Hd and e , 3.16 ddd, 1H, J 14.9, 5.4, 2.3, Ha , 2.72 d, d, d, 1H, J 14.9, 2.1, 2,Hb mass spectrum m e 211 M , 168, 142, 127, 84. EXAMPLE 2Preparation of 4S 1 t Butyldimethylsilyl 4 iodomethylazetidin 2 oneEMI27.1 t butyldimethylchlorosilane 7.51 g, 49.8 mmol is added in one portion to an ice cold, stirring solution of 4S 4 iodomethyl azetidin 2 one 10,0g, 47.4mmol and triethylamine 5.04g, 49.8 mmol in anhydrous dimethylformamide 100 ml . A voluminous white precipitate forms almost immediately. The reaction mixture is stirred at 0 5 for 1 hour and then allowed to warm to room temperature. Most of the solvent is removed under vacuum to give a.residue which is partitioned between diethyl ether 250 ml and water.The ethereal phase is washed with 2.5N hydrochloride acid 50 ml , water 3x50 ml , and brine, dried with magnesium sulfate, filtered, and evaporated under vacuum to provide 4S l t butyldimethylsily 4 iodomethyl azetidin 2 one 15.1 g as a white solid. Recrystallization from petroleum ether ethyl ether gives the product as colorless plates, mp 71 720 n.m.r. CDCl3 , 3.l8 m,l , 2.6 3.6 2 overlapping d of AB, 4 1.0 S,9 ,j0.3 S,6 ,0.25 S,6 . Preparation of 45 4S l t Butyldimethylsilyl 4 2,2,2 tri methylthio ethyl axetidin 2 oneEMI28.1 n Butyllithium 19.4 ml of 2.5M hexane,solution, 48.5 mmol is added slowly by syringe to a solution of tri methylthio methane 7.47g, 48.5 mmol in 150 ml of freshly distilled THF at 780C. The resulting solution is stirred at 78C for 30 min.prior to the addition of a solution of 4S 1 tert butyldimethylsilyl 4 iodomethylazetidin 2 one 15.0g, 46.15 mmol in 50 ml of THF. This solution is stirred at 780C for 30 min., then quenched by addition of saturated aqueous ammonium chloride solution. The reaction mixture is allowed to warm to room temperature, then poured into ether 250 ml , washed with water 2x100 ml brine 100 ml and dried over magnesium sulfate.Removal of solvents in vacuo gives an oil which is crystallized from petroleum ether to give 13.3g 82 of 4S 1 t butyldimethyl silyl 4 2,2,2 tri methylthio ethyl azetidin 2 one as colorless prisms. m.p. 61 62 C. IR CHC13,CM 1 2913, 2850,1730 n.m.r. CDCl3 4.0 m,l , 3.35 dd,1,J 5,16 , 2,83 dd,1,J 3,16 S 2,5 ABq,2 i 2,15 s,9 , 0.98 s,9 , 0.25 z,6 EXAMPLE 4Preparation of 3S, 4R 1 t butyldimethylsily 3 R 1 hydroxyethyl 4 2,2,2 tri methylthio ethyl azetidin 2 oneEMI29.1 n Butyllithium 14.8 ml of 2.5N hexane solution, 37.0 mmol is added by syringe to a solution of diisopropylamine 3.74g, 37.0 mmol in 180 ml of freshly distilled tetrahydrofuran at 780C.The resulting solution is stirred at 780C for 15 min prior to the addition of a solution of 4S l t butyldimethylsilyl 4 2,2, 2 tri methylthio ethyl azetidin 2 one 12.34g, 35.16 mmol in 35 ml of tetrahydrofuran. This solution is stirred at 780C for 10 min prior to the addition of acetaldehyde 4.62g, 105 mmol . The solution is stirred for an additional 5 min. at 780C and then quenched by addition of saturated aqueous ammonium chloride solution, and allowed to warm to room temperature. The mixture is poured into 250 ml of ether and washed with water 2 x 100 ml and brine and dried over magnesium sulfate.Removal of solutions in vacuo gives an oil which is chromatographed on a silica gel column 1 1 ether petroleum ether to give 3S,4R 1 t butyldimethylsilyl 3 R l hydroxyethyl 4 2, , 2Ttri methylthio ethyl azetidin 2 one 3. 1g, 5Q.4tL at Rf 0.2. The product can be recrystallized from petroleum ether. Alternatively, t trans R product can be isolated from the crude reaction mixture by direct crystallization from a petroleum ether solution. EXAMPLE 5Preparation of 3S,4R l t Butyldimethylsilyl 3 l oXoethyl 4 2,2,2, trilmethylthio ethyl azetidin 2 one EMI30.1 A. n Butyllithium 2.43 ml of 2.4m solution, 5.84 mmol is added by syringe to a solution of diisopropylamine 591 mg, 5.84 mmol in 25 ml of freshly distilled tetrahydrofuran at 780C. The resulting solution is stirred at 780C for 15 minutes prior to the addition of a solution of 4R 1 t butyldimethylsilyl 4 2,2,2 tri methylthio ethyl azetidin 2 one 1.00 g, 2,85 mmol in tetrahydrofuran 5 ml . This solution is stirred at 78 C for 15 minutes, then added via a Teflon tube to a mixture of N acetylimidazole 642 mg, 5.84 mmol in 25 ml of THF at 780C.The resulting yellow reaction mixture is stirred at 780C for 10 minutes, then quenched by addition of saturated aqueous ammonium chloride solution. The mixture is diluted with ether 200 ml and washed with 2.5N hydrochloric acid solution 50ml , water 50 ml and brine 50 ml and dried over magnesium sulfate. Removal of solvents in vacuo gives a yellow oil which is chromatographed on silica gel 30 ether in petroleum ether to yield 3S, 4R l t butyldemethylsilyl 3 1 oxoethyl 4 2,2,2 tri methylthio ethyl azetidin 2 one. n.m.r. CDCl3 4.42 m,1 , 4.32 d,l 2.35 m,2 , 2.32 s,3 , 2.2 s,9 , 0.98 s,9 , 0,3 2s,6 . B. Trifluoroacetic anhydride 400 mg., 1.905 mmol is added by syringe to a solution of dimethyl sulfoxide 2.53 mmol in dry methylene chloride 5 ml at 780C.The resulting mixture is stirred at 780C for 30 minutes prior to the addition of a solution of 3RS, 4R 1 t butyldlimethylsilyl 3 RS l hydroxyethyl 4 2,2,2tri methylthio ethyl azetidin 2 one 500 mg., 1.27 mmol in dry CH2cl2 1 ml . The resulting solution is stirred for 30 minutes prior to the addition of triethylamine 360 mg., 3.56 mmol . The cooling bath is removed.After 40 minutes, the reaction mixture is diluted withCH2C12, washed with water and brine and dried over magnesium sulfate. Removal of solvents in vacuo gives an oil which is purified as above. Yields 432 mg. 86 . EXAMPLE 6Preparation of 3S,4 R l t butyldimethylsilyl 3 R 1 hydroxyethyl 4 2,2,2 tri methylthio ethyl azetidin 2oneEMI32.1 K 5electride 3,64 mi of 0.5M, 1.82 mmol is added by syringe to a mixture of potassium iodide t126 mg.,0.758 mmol and 3S,4R 1 t butyl dimethylsilyl 3 1 oxoethyl 4 2,2,2 tri methylthio etnhylazetidin 2 one 298 mg, 0758 mmol in freshly distilled ethyl ether 8 ml at room temperature. The resulting mixture is stirred at room temperature for 2.5 hours, then quenched by the addition of acetic acid 218 mg., 3.64 mmol . The resulting mixture is diluted with ethyl acetate 25 ml and filtered through celite.Removal of solvents in vacuo gives an oil which is chromatographed on silica gel ether petroleum ether to yield 252 mg of 3S, 4R l t butyldimethylsilyl 3 l R l hydroxyethyl 4 2 ,2,2 tri methylthio ethyl azetidin 2 one. N.M.R. R isomer, CDCl3 D2O 4.15 dg,1 , 3.95 ddd,1,J 9.5,2.3 , 3.26 dd,1,J 8,2.3 , 2.37 m,2 , 2.16 s,9 , 1.37 d,3,J 6,6 , 1.0 s,9 , 0.26 s,6 . EXAMPLE 7Preparation of C3S,4R l Ct Butyldimethylsilyl 3 AR l hydroxyethyl 4 carbomethoxymethylazetidin 2 EMI33.1 Mecuric chloride 12.37g, 45.6 mmol is added in one portion to a solution of 3S,4R l t butyldimethylsilyl 3 R 1 hydroxyethyl 4 2,2,2 tri methylthio ethyl azetidin 2 one 6,0g, 15.2 mmol in 250 ml of absolute methanol at O C. The resulting mixture heavy white precipitate is stirred at 0 C for 3 min., then quenched by addition of sodium bicarbonate 8.99 g,l07mmol . This mixture is then filtered and the solid residue is washed with additional methanol.The combined filtrate and washings are concentrated in vacuo and the residue is partitioned between ethyl acetate and saturated aqueous ammonium chloride solution. The organic phase is separated, washed with saturated aqueous ammonium chloride solution, water and brine and dried over magnesium sulfate.Removal of solvents in vacuo gives an oil which is chromatographed on a silica gel column 3 2 cyclohexane ethyl acetate to yield 35, 4R 1 t butyldimethylsilyl 3 1 R 1 hydroxyethyl 4 carbomethoxymethyl azetidin 2one. EXAMPLE 8Preparation of 3S,4R 1 t Butyldimethylsilyl 3l R l t butyldimethylsilyloxy ethyll 4 arbometh methvlazetidin 2 one EMI34.1 t Butyldimethylchlorosilane 940 mg, 6.25 mmol is added in one portion to a solution of 35, 4R 1 t butyldimethylsilyl 3 R 1 hydroxyethyl 4 carbomethoxymethylazetidin 2 one 1.88g, 6.25 mmol and triethylamine 1.27 g, 6.25 mmol in 15 ml of anhydrous diemthylformamide at 0.C. After 15 min. at 0 C the cooling bath is removed and the reaction mixture is stirred at room temperature for 24 hrs.Ether 100 ml is added and the mixture is filtered, then washed with 2.5N hydrochloric acid 20 ml , water 3x20 ml and brine. The organic phase is dried over magnesium sulfate, then concentrated in vacuo.The residue is chromatographed on silica gel 7 3 petroleum ether ether to yield 3S, 4R l t butyldimethyl sityl 3 R l tt butyldimethylsilyloxy ethyl 4 carbomethoxymethylazetidin 2 one. n.m.r. CDCl3 4.1 m,2 , 3.68 S,3 , 3,09 dd,1,J 4.3,2.7 , 2.8 ABq,2 , 1.17 d,3, J 6.6 , 0.98 s,9 , 0.89 s,9 , 0.23 s,6 , 0.1 s,6 . EXAMPLE 9Preparation of 3S,4R l Lt Butyldirnethylsilyl 3 R 1 t butyldimethylsilyloxy ethyl 4 2 oxoethyl azetidin 2 one EMI35.1 Diisobutylaluminum hydride 3.72 ml of 0.91 M in hexane, 3.38 mmol is added slowly by syringe to a solution of 3S, 4R 1 t butyldimethylsilyl 3 R 1 tbutyldimethylsilyloxy ethyl 4 carbomethoxymethyl azetidin 2 one 936 mg, 2.26 mmol in 25 ml of freshly distilled toluene at 780C. The resulting solution is stirred at 78 C for 3 hrs., then quenched by addition of 2.5N hydrochloric acid 5 ml .The resulting mixture is stirred for 2 min., then poured into a separatory funnel containing 100 ml of ether and 50 ml of 1.25N hydrochloric acid saturated with tartaric acid.The organic phase is separated and the aqueous phase is extracted with ether 2x50 ml . The combined organic phases are washed with brine and dried over magnesium sulfate. Removal of solvents in vacuo gives a white solid which is recrystallized from ether petroleum ether to give 3S,4R 1 t butyldimetjylsilyl 3 R 1 t butyldimethylsilyloxy ethyl 4 2 oxoethyl azetidin 2 one m.p. 115 116 C n.m.r. CDCl3 4.1 m,1 , 4.03 m,1 , 2.7 3.2 m,3 , 1.23 d,3,J 6.4 , 1.08 s,9 , 0.9 s,9 , 0.25 s,6 , 0.1 s,6 , 9.83 t, 1, J 1.4 . EXAMPLE 10Preparation of 3S, 4R 1 t Butyldimethylsilyl 3 R 1 t butyldimethylsilyloxy ethyl 4 3benzyloxycarbonyl 2 hydroxypropyl azetidin 2 oneEMI36.1 n Butyllithium 1.81 mmol is added by syringe to a solution of diisopropylamine 1.81 mmoi in 9 ml of freshly distilled tetrahydrofuran at 780C. The resulting solution is stirred for 15 min at 780C Benzyl acetate 1.81 mmol is then added dropwise by syringe and the resulting solution is stirred at 780C for 20 min.A solution of 3S, 4R l t butyldimethyl silyl 3 R l t butyldimethylsilyloxy ethyl 4 2 oxoethyl azetidin 2 one 1.64 mmol in 3 ml of anhydrous tetrahydrofuran is added slowly by syringe.The reaction mixture is stirred at 780C an additional 15 min and then quenched by addition of saturated aqueous ammonium chloride solution. Ethyl acetate 50 ml is added and the organic phase is separated, washed with water 2x10 ml and brine and dried over magnesium sulfate. Removal of solvents in vacuo gives a white solid which is chromatographed on a short silica gel column 40 ether in petroleum ether to yield 3S,4R l t butyldimethylsilyl 3 R l t butyldimethyl silylOxy ethyl 4 3 benzyloxycarbonyl 2 hydroxypropyl azetidin 2 oneS n.m.r. CDC13 7.32 s,5 , 5,1 s,2 , 4.0 m,3 , 2,4 3,8 m,4 , 2.0 m,2 , 1.25 overlapping d, 3 , 0.05 s,9 , 0.9 s,9 , 0.3 s,6 , 0.18 s,6 . EXAMPLE 11Prepaation of 3S,4R 1 t Butyldimethylsilyl 3 R l t butyldimethylsIlyloxy ethyll 4 3 4 nitrobenzyl oxycarbonyl 2 hydroxypropyl azetidin 2 oneEMI37.1 A mixture of 3S,4R 1 t butyldimethylsilyl 3 R 1 t butyldimethylsilyloxy ethyl 4 3benzyloxycarbonyl 2 hydroxypropyl azetidin 2 one 1.00 mmol , sodium bicarbonate 1.00 mmol and 10 Pd C in 20 ml of 4 1 tetrahydrofuran H2O is hydrogenated at 40 psi on a Parr shaker for 30 min. The mixture is then filtered through Celite and the catalyst is washed with 10 ml of water. The combined washings and filtrate are concentrated i.v. to 2 ml and lyophilized. The resulting fluffy white solid is dissolved in 5 ml of anhydrous dimethylformamide and p nitrobenzyl bromide 216 mg, 1.00 mnl is added in one portion.The resulting solution is stirred at room temperature for 3 hrs, then diluted with ether 50 ml and washed with water 3x10 ml and brine and dried over magnesium sulfate. The solvents are removed in vacuo and the residue is chromatographed on silica gel to yield 3S,4R l t Butyldimethylsilyl 3 R 1 t butyldimethylsilyloxy ethyl 4 3 4 nitrobenzyl oxycarbonyl 2 hydroxypropyl azetidin 2 one, n.m.r. CDCl3 .85 2d x atin,4 , S5,26 s,2 , 4.2 m,3 , 2,5 3.6 m,4 2.0 m,2 , 1.4 2 overlapping d,3 , 1.0 2s, 18 , 0.25 2s,12 . EXAMPLE 12Preparation of 35, 4R 1 t Butyldimethylsilyl 3 R 1 t butyldimethylsilyloxy ethyl 4 3 4nitrobenzyl oxycarbonyl 2 oxopropyl azetidin 2 oneEMI38.1 Anhydrous chromium trioxide 10.0 mmol is added to a soution of anhydrous pyridine 20.0 mmol in 30 ml of anhydrous methylene chloride. After stirring at room temperature for 15 min., the reaction mixture is treated all at once with a solution of 3S,4R 1 t butyldimethylsilyl 3 R 1 t butyldimethylsilyloxy ethyl 4 3 4 nitrobenzyl oxycarbonyl 2 hydroxypropyi azetidin 2 one 1.00 mmol in annydrous methylene chloride 8 ml . The resulting mixture is stirred at room temperature for 5 min.The CX2C12 layer is decanted from the dark, tarry residue which is triturated with more CH2C12. The combined CH2C12 phase is concentrated in vacuo. The residue is triturated with ether 100 ml and the ether extracts are filtered.The filtrate is washed with 5 aqueous sodium bicarbonate solution, 2.5N HC1, 5 NaHCO3 and brine, dried over magnesium sulfate and concentrated in vacuo to yield 35 4R 1 t butyldimethylsilyl 3 R 1 t butyldimethyl silyloxy ethyl 4 3 4 nitrobenzyl oxycarbonyl 2oxopropyl azetidin 2 one. n.m.r. CDCL3 7.85 2d aromatic, 4 , 5.27 s,2 , 4.05 m,2 , 2.6 s,2 , 2.4 3.2 dd over lapping ABq,3 , 1.2 d,3,J 6.6 , 0.9 2s,18 , 0.22 s,6 , 0.05 s,6 . EXAMPLE 13Preparation of 3S,4R 3 t R l hydroxyethyl 4 3 4 nitrobenzyl oxycarbonyl 2 oxopropyl azetidin 2 oneEMI39.1 3s,4R 1 t butylaimethylsilyl 3 R Il t butyl dimethylsilyloxy ethyl 4 3 4 nitrobenzyl oxycarbonyl2 oxopropyl azetidin 2 one 7.9 mmol is dissolved in 160 ml of 9 1 v v methanol water and cooled to 0 C. Concentrated hydrochloric acid 2.75 ml is added and the resulting solution is stirred at 0 C for 15 min., then allowed to warm to room temperature. The solution is stirred at room temperature for 2.5 hrs, then diluted with ethyl acetate 200 ml and washed with water, saturated aqueous sodium bicarbonate solution and brine, dried over magnesium sulfate and concentrated in vacuo to yield 3S, 4R 3 R 1 hydroxyethyl 4 3 4 nitrobenzyl oxycarbonyl 2 oxopropyl azetidin 2 one. EXAMPLE 14Preparation of 3S,4R 3 R 1 hydroxyethyl 4 3 4 nitrobenzyl oxycarbony1 2 oxo 3 diazoropyl azetidin 2 one EMI40.1 wiethylamine 263 mg, 2.6mmol is added by syringe. to a mixture of 3S,4R 3 R l hydroxyethyl 4 13 8 nitrobenzyB oxycarbonyl 2 oxopropyl azetidin 2 one 253mg, 0.72 mmol and p carboxybenzene sulfonylazide 196 mg, 0.84 mmol in dry acetanitrile 6 ml at0 C. When addition is complete the cooling bath is removed and the reaction mixture is stirred at room temperature for 1 hour. The mixture is then diluted with ethyl acetate 50 ml and filtered.The filtrate is concentrated in vacuo and the residue is chronatographed on a short silica gel column.. ethyl acetate to yield 222 mg, 81 overall from 3S, 4R 1 t butyldimethyl silyl 3 t R l t butyl dimethylsilyloxy ethyl 4 13 4 nitrobenzyl oxycarbonyl 2 oxopropyl azetidin 2 one of 3S,4R 3 R 1 hydroxyethyl 4 3 4 nitrobenzyl oxycarbonyl2 oxo 3 diazopropyl azetidin 2 one as a white solid m.p. dec. 1630C. IR CHC13, CM 1 3410, 2132, 1756, 1718, 1650, 1350, 1280, 1120 n.m.r. CDCl3 7.9 2d aromatic,4 , 5.4 s,2 , 6.2 brs,1 , 4.1 m,2 , 2.6 3.6 m,4 , 1.32 d,3,J 6.2 . EXAMPLE 15Preparation of 5R,6S p Nitrobenzyl 6 R 1 hydroxyethyl 1 azabicyclo 3.2.0 heptap 3,7 dione 2 craboxylateEMI41.1 A suspension of 3S,4R 3 R 1 hydroxyethyl 4 3 4 nitrobenzyl oxycarbonyl 2 oxo 3 diazopropyl azetidin2 one 56.4mg, 0.15 mmol and rhodium II acetate 0.1 mg in dry benzene 3ml is deoxygenated by bubbling through nitrogen for 10 minutes. The mixture is then heated to 780C for 1 hour. During heating the solid starting material gradually goes into solution. The mixture is then cooled, filtered to remove the catalyst, and the filtrate is concentrated in vacuo to yield 5R, 6S p nitrobenzyl 6 f R 1 hydroxyethyl 1 azabicyclo 3.2.0 heptan 3,7.dione 2 carboxy late, 51 mg. 98 as a colorless oil which slowly crystallized t room temperature 220C .Physical Properties EMI41.2 PNB p nitrobenzyl n.m.r. 300MHz, CDC1 8.26, 7.54 aromatic, 4 , 5.29 AB,2 , 4.77 s,l , 4.32 dg.1,J 6.6,7 , 4.16 ddd,l,J 7,7.5,2.2 , 3.21 dd,1,J 7,2.2 , 2.94 dd,1,J 19.5,7 2.50 dd,1,J 19.5,7.5 , 2.2 brs,l , 1.37 d,3,J 6.6 .I.R. CHCl3,CM Ú 1770, 1758, 1610, 1522, 1353 m.p. 110 111 C. EXAMPLE 16Preparation of p Nitrobenzyloxycarbonylaminoethanethiol EMI42.1 To 600 ml diethyl ether Et2O 75 ml H2 0 in an ice bath with stirring is added 3.2 g cysteamine hydrochloride mw 114 28.1 mmole . A solution of 7.14 g NaHCO3 mw 84 85 mmole in 75 ml H2O is added. The ice bath is removed, and at room temperature a solution of 6.75 g nitrobenzylchloroformate mw 216 31.3 mmole in 270 ml Et2O is added dropwise over a period of one hour. After 10 additional minutes, the layers are separated. The ether layer is extracted with 150 ml 0.25 N HCl, and then with 200 ml brine. Each aqueous layer is then backwashed successively with 100 ml Et2O.The combined Et2O layers are dried over anhydrous MgSO4, filtered, and concentrated under a N2 stream. The crystalline residue is slurried in a small amount of ether, filtered, and the pale yellow crystals are dried under high vacuum to give 4.7 g. nitrobenzyloxycarbonylaminoethanethiol 65 yield .NMR CDC13 8.18 d, J 8Hz, aromatic protons ortho to nitro , 7.47 d, J 8Hz, aromatic protons meta to nitro , 5.27 NH , 5.20 s, C 2 NH , 2.67 m, CH2 5H , 1.35 t, J 8.5Hz, SH in ppm downfield from TMS. IR CHC13 solution carbonyl 1725 cm . M.S. molecular ion 256, M 47 at 209, M 136 at 120, CH2pNO2 at 136. EXAMPLE 17Preparation of 5R,6S p Nitrobenzyl 3 2 p nitrobenzyloxycarbonyl amino ethylthio 6 R 1 hydroxyethyl 1 azabicyclo 3,2,0 hept 2 en 7 one 2 carboxylateEMI43.1 5R,5S p Nitrobenzyl 6 R 1 hydroxyethyl 1 azabicyclo 3,2,0 heptan 3,7 dione 2 carboxylate 51 mg, 0.14 mmol is dissolved in acetonitrile 3 ml an the resulting solution is cooled to 0 C. Diisopropylethylamine 22 mg, 0.17 mmol s added by syringe and the resulting solution is stirred at 0 C for 1 rninute prior to the addition of z solution of freshly recrystallized p toluene sulfonic anhydride 51 mg., 0.156 mmol in dry acetonitrile 1 ml .The resuiting solution is stirred at 0 C for 1 hour to provide SR,6Sjp nitrobenzyl 3 p toluenesulfonyloxy 6 R 1 hydroxyethyl 1 azabicyclo 3.2.0 hept 2 en 7 one2 carboxylate, then cooled to 250C Diisopropylethylamine 80.5 mg, 0.624 mmol is added b syringe followed shortly thereafter by a solution of N p nitrobenzyloxycarbonylcysteamine 40 mg. 0.156 mmol in 1 ml of dry acetonitrile. The reaction mixture is then stored in a refrigerater for 70 hr. The mixture is diluted with 25 ml of ethyl acetate washed with brine and dried over magnesium sulfate.Solvents are removed in vacuo to yield a yellow oil which is chromatographed on a silica gel plate ethyl acetate, Rf 0.4 to yield SR, 6S p nitrobenzyl3 2 p nitrobenzyloxycarbonyl amino ethylthio 6 R 1hydroxyethyl 1 azabicyclo 3,2,0 hept 2 en 7 dione2 carboxylate as a yellow solid, m.p. 167 1690C.IR Nujol mull 1773 and 1690 cm 1 n.m.r. CDCl3 7.54 8.26 overlapping ABq,4 , 5.40 ABq,2 , 5.22 s,2 , 4.27 m,2 , 3.47 m , 3.23 dd,1 3.14 dd,1 3.40 dd,1 , 3.04 m,2 1.37 d,3 EXAMPLE 18Preparation of ThienamycinEMI44.1 A mixture of N p nitrobenzyloxycarbonyl thienamycin pnitrobenzyl ester 10mg, 0.017 mmol and 10 Pd C Bolhofer type in tetrahydrofuran 2ml , 0.10 dipotassium hydrogen phosphate solution 1.4 ml and 2 propanol 0.2ml is hydrogenated at 40 psi on the Parr shaker for 30 minutes.The mixture is then filtered and the catalyst is washed with water 3x3ml . The combined filtrate and washings are extracted with ethyl acetateethyl ether then concentrated to ml and lyophilized. The resulting white powder is identical to natural thienamycin in all respects. EXAMPLE 19Preparation of Benzyl 4 S azetidin 2 one 4 carboxylateEMI45.1 A mixture of dibenzyl S aspartate p toluenesulfonic acid salt 48.6g, 3.1 mole , diethylether 300ml , water 100ml , and saturated aqueous potassium carbonate 3 Omi is shaken vigorously. The layers are separated and tiie aqueous portion is extracted with more ether 2x100ml . The combined ethereal extracts are washed with brine, dried with magnesium sulfa .e, filtered, and evaporated under vacuum to afford dibenzyl S aspartate 31.5g as a water white liquid. The dibenzyl S aspartate in anhydrous diethyl ether 200ml is cooled in an ice bath and stirred under a nitrogen atmosphere while trimethylchlorosilane 12.7ml, O.lmole and triethylamine 14.Oml, 0.1 mole are added successively over a few minutes. The cooling bath is removed and the mixture is stirred at room temperature for 2 hours. The mixture is then filtered under a blanket of nitrogen into a three neck, one liter, round bottom flask fitted with a sintered glass funnel, vacuum nitrogen inlet, and a mechanical stirrer. Additional anhydrous ether 2x50ml is used to wash the precipitate of tri ethylammonium hydrochloride.The funnel containing the precipitate is replaced by a dropping funnel and the etheral filtrate of dibenzyl 4S N trimethyl silyl aspartate is cooled in an ice bath and stirred under a nitrogen atmosphere while 2.1M t butyl magnesium chloride in ether 48 ml, 0.1 mole is added drop wise over 9 minutes. A gummy precipitate forms during the addition. The cooling bath is then removed and the mixture is allowed to stand at room temperature overnight. The mixture is cooled in an ice bath and stirred vigorously while ammonium chloride saturated 2N hydrochloric acid 100 ml is added over a few minutes.After stirring vigorously several more minutes, the mixture is diluted with water 100 ml and ethyl acetate 100 ml and the layers are separated. The aqueous portion is extracted with ethyl acetate 2x100ml .The combined organic solution is washed with water 100ml , 5 aqueous sodium bicarbonate 100ml , and brine 100ml , dried with magnesium sulfate, filtered, and evaporated under vacuum to a yellow semi solid. Crystallization of this material from methylene chloride 100 ml petroleum ether 300 ml provides the azetidinone product 8.2g as an off white powder.The mother liquors are evaporated and the residue crystallized from diethyl ether to afford additional product 2.5g as a pale yellow product. The two crops are combined and recrystallized from methylene chloride to yield benzyl 4S azetidin 2 one 4 carboxylate 9.5g as nearly colorless crystals mp 139 141 alpha D 40,50 C2.0 in CHCl3 IR CHC13 3425, 1778, 1746cm 1 1 NMR CDC13 C3,00 ddd, H 3ss , 3.35 ddd,H 3 , 4.20 dd,H 4 , 5 22 s,CH , 6.48 m,NH , 7.35 s,phenyl mass spectrum m e 205 M , 163, 91, 70, 43. EXAMPLE 2Q 4S 1 t butyldimethylsilyl 4 2,2 trimethylenedithia 2 trimethylsilylethyl azetidin 2 oneEMI47.1 A solution of 2 trimethylsilyl 1,3 dithiane 3.78g, 19.69 mmole in anhydrous tetrahydrofuran 25 ml at 0 C is stirred under nitrogen while n butyllithium in hexane 20.67 mmol is added dropwise. The resulting solution is stirred for 15 min. at 0 C then cooled to 780C dry ice acetone . A solution of 4S 1 t butyldimethylsilyl 4 iodimethylazetidin2 one 6.40g, 19.69 mmol in 20 ml of anhydrous tetrahydrofuran is added slowly by syringe over ca. 5 min.The resulting solution is stirred at 780C for 1 hr., then quenched by the addition of saturated aqueous ammonium chloride solution 10 ml and allowed to warm to room temperature 220C . The mixture is poured into a separatory funnel containing ethylether 200 ml and water 100 ml . The organic phase is separated, washed with brine and dried over anhydrous magnesium sulfate. The solvent is removed in vacuo to yield a yellow oil.This material is filtered through a short silica gel column 25 ether in petroleum ether to give 6.15g 80 of 4S l t butyldimethylsilyl 4 2,2 trimethylenedithia 2 trimethysilylethyl azetidin 2 one as a white solid, m.p. 71 73 C. n.n.r. CDCl3 3.9 1H, m, H 5 , 2.2 3.6 8H, overlapping m ,2.0 2H, m, SCH2CH2CH2S , 0.99 9H, S, Si , 0.23 15H, br.S, CH3 2Si CH3 3Si .IR CHC13 2930, 2855, 1723 cm 1. EXAMPLE 21 3,R,S,4R l t Butyldimethylsilyl 3 R,S l hydroxyethyl 4 2,2 trimethylenedithia 2 trimethylsilylethyl azetidin 2 one EMI49.1 A solution of diisopropylamine 10.5 mmol in anhydrous tetrahydrofuran 40ml is cooled to 780C dry ice acetone and stirred under nitrogen atmosphere while n butyllithium in hexane 10.5 mmol is added slowly by syringe. After 15 min., a solution of 4S l t butyldimethylsilyl 4 2,2 tri methylenedithia 2 trimethylsilyl ethyl azetidin 2 one 10.0 mmol in anhydrous tetrahydrofuran 12ml is added slowly by syringe. The resulting solution is stirred at 780C for 20 min. prior to the addition of acetaldehyde 30.0 mmol .After an additional 10 min. at 780C the reaction is quenched by the addition of saturated aqueous ammonium chloride solution 10 ml and allowed to warm to room temperature.The reaction mixture is diluted with ethyl acetate 150 ml and washed with 2.5N hydrochloric acid solution 50 ml , water 50 ml and brine 50ml and dried over magnesium sulfate. Removal of solvents in vacuo gives a white solid 4.6g which is chromatographed on 250g of silica gel 1 1, ether petroleum ether to give four main product fractions with a total weight of 4.185g 96.7 . Fraction No. l Rf 0.62, 85mg. Fraction No. 2 Ref 0.43, 1.95g 45 , 3S,4R l t butyldimethyl silyl 3 r s l hydroxyethyl 4 2r2 trimethylenedithia 2 tri methylsilylethyl azetidin 2 one. Fraction No. 3 Rf 0.34, 150 mg. mixture.Fract n No. 4 Rf 0.28, 2.0g 46 , 3S, 4R 1 tibutyldimetnylsilyl 3 R 1hydroxyethyl 4 2,2 trimethylenedithia 2 trimethylsilylethyl azetidin 2 one. EXAMPLE 22 3S, 4R 1 t Butyldimethylsilyl 3 1 oxoethyl 4 2,2 trimethylenedithia 2 trimethylsilylethyl zzetidin 2 one Step A EMI51.1 A solution of diisopropylamine 6.0 mmol in anhydrous tetrahydrofuran 25 ml is cooled to 780C dry ice acetone and stirred under a nitrogen atmosphere while n butyllithium in hexane 6.0 mmol is added by syringe. After 15 min., a solution of 4S 1 t butyldimethylsilyl 4 2,2 trimethylenedithia 2 trimethylsilylethyl azetidin 2 one 3.0 mmol in anhydrous tetrahydrofuran 3 ml is added dropwise by syringe. The resulting sdbtion is stirred at 78 C for 30 min., then added through a Teflon tube to a mixture of N acetylimidazole 6.0 mmol and anhydrous tetrahydrofuran 25 ml at 780C.The resulting yellow reaction mixture is stirred at 780C for 10 min., then quenched by addition of saturated aqueous ammonium chloride solution. The reaction mixture is poured into ether 200 ml and extracted with 2.5N hydrochloric acid solution 50 ml , water 50 ml and brine and dried over magnesium sulfate. Removal of solvents in vacuo gives a yellow oil which is chromatographed on silica gel tether petroleum ether 1 2 to yield 3S,4R l t butyl dimethylsilyl 3 1 oxoethyl 4 2,2 trimethylenedithia 2 trimethysilylethyl azetidin 2 one. Step B EMI52.1 Trifluoroacetic anhydride 6.0 mmol is added by syringe to a solution of dimethylsulfoxide 8.0 mmol in anhydrous methylene chloride 10 ml at 780C.The resulting mixture is stirred at 78 C for 20 min., during which time a white precipitate forms. A solution of 3RS, 4R 1 t butyldimethylsilyl 3 RS 1 hydroxyethyl 4 2,2 trimethylenedithia 2 trimethyl silylethyl azetidin 2 one 4.0 mmol in anhydrous methylene chloride 10 ml is added by Syringe and the resulting mixture is stirred at 780C for 40 min. Triethylamine 11.2 mmole is added by syringe and the cooling bath is removed. After 1 hr. the reaction mixture is diluted with CH2C12 100 ml and washed with 2.5N hydrochloric acid solution 50 ml , water 50 ml and brine and dried over magnesium sulfate. Purification as above yields 3S, 4R l t butyldimethylsilyl 3 1 oxoethyl 4 2,2 trimethylenedithia 2 trimethylsilylethyl azetidin 2 one. n.m.r. CDC13 4.23 1H, BrS, H 6 , 64.2 1H, m, H 5 ,j2.1 3.2 6H, m , 2.27 3H, S, CH3 C O , 2.0 2H, m, SCH2CH2CH2S , 0.96 9H, S, Si , 0.25 15H, br.S CH2 2Si tCE3 3Si . EXAMPLE 23 3S, 4R 1 t Butyldimethylsilyl 3 R 1 hydroxy ethyl 4 2,2 trimethylenedithia 2 trimethylsilyl ethyl azetidin 2 oneEMI53.1 K Selectride potassium tri sec butylborohydride 4.8 mmol in a solution of tetrahydrofuran is added dropwise by syring to a mixture of 3S, 4R 1 t butyldimethylsilyl3 3 1 oxoethyl 4 2,2 trimethylene dithia 2 trimethylsilylethyl azetidin 2 one 2.0 mmol and potassium iodide 2.0 mmol in anhydrous ether 20 ml at room temperature. The resulting mixture is stirred at room temperature for 2.5 hr., then quenched by addition of glacial acetic acid 9.6 mmol . The resulting mixture is diluted with ethyl acetate 50 ml and filtered through celite.The solvents are removed in vacuo to give an oil which is chromatographed on silica gel 1 1, ether petroleum ether to give 3S,4R 1 t butyldimethylsilyl 3 R 1 hydroxyethyl 4 2,2 trimethylenedithia 2 trimethylsilylethyl azetidin 2one as a white solid, n.m.r. CDC13 D20 4.23 1H, dq. J 7.5,7,H 9 2.78 1H, ddd, J 7.5, 3, 2.2, H 5 3.18 1H, dd, 7.5, 2.2, H 6 , 2.5 3.0 4H, m, SCH2CH2CH2S 2.35 2H, m, CH2 S , S2.0 2H, m, SCH2CH2CH2S 51.33 3H, d, J 7, CH3 , 0.98 9H, S, Si 0.26 15H, br.S, CH3 2 Si CH3 3Si . 3S,420 1 t Butyldimethylsilyl 3 R l hydroxyethyl 4 2 oxo 2 trimethylsilylethyl azetidin 2 oneEMI54.1 A mixture of mercuric oxide .6.93 mmol ,mercuric chloride 10.2 mmol and 3S,4R l t butyldimethylsilyl 3 R 1 hydroxyethyl 4 2,2 trimethylenedithia 2 trimethylsilylethyl azetidin 2 one 4.62 mmol in 5 aqueous methanol 25 ml is heated at reflux for 45 min. During this time, the color of reaction mixture changes from orange to off white. The mixture is cooled and filtered and the filter cake is washed several times with methanol.The combined filtrate and washings are concentrated to 5 5 ml in vacuo, then diluted with ethyl acetate 100 ml and washed with saturated aqueous ammonium chloride solution 2 x 50 ml and brine. The organic phase is dried over magnesium sulfate and concentrated in vacuo to yield a pale yellow oil.This material is chromatographed on silica gel ether to yield 3S, 4R 1 t butyldimethylsilyl 3 R 1 hydroxyethyl 4 2 oxo 2 trimethylsilylethyl azetidin 2 one, 1.38g 87 , as a white solid, m.p. 82 840C. n.m.r. CDC13 D20 3.6 4.3 2H, m, H 5, H 8 3,12 2H, center of d of AB, J 18, 4, 8.5, CH2 C S 2.7 1H, dd, J 7.5,2, H 6 , 1.27 3H, d, J 6,5, CH3 0.99 9H,s, Si , 0.3 15H, br.S, CH3 3 Si CH3 2Si .I.R. CHCl3 3450, 2930, 2855,1737, 1635 cm EXAMPLE 24 EXAMPLE 25 3S,4R 1 t Butyldimethylsilyl 3 R 1 hydroxyethyl 4 carboxymethyl azetidin 2 oneEMI55.1 m Chloroperbenzoic acid 1.00 mmol is added to a solution of 3S,4R l t butyldimethylsilyl 3 R 1 hydroxyethyl 4 2 oxo 2 trimethylsilylethyl azetidin 2 one 1.00 mmol in chloroform 4 ml .The resulting solution is heated at reflux for 4 hr, then cooled, concentrated in vacuo, and the residue chromatographed on silica gel 2 glacial acetic acid in methylene chloride . 3S, 4R 1 t butyldimethylsilyl 3 R l hydroxyethyl 4 carboxymethyl azetidin 2 one, 238 mg 83 is isolated as a colorless solid,Rf 0.25. n.m.r. CDCl3 D20 .6 4.3 2H, m, H 5, H 8 , 2.98 1H, dd, J 7, 2.1 H 6 , 2.7 2H,d of ABq CH2 CO2H , 1.29 3H, d, J 6, CH3 s 0.95 9H, S, Si , 0.25 6H, S, Ch3 2 Si . EXAMPLE 26 3S, 4R 1 t Butyldimethylsilyl 3 R 1hydroxyethyl 4 3 p nitrobenzyloxycarbonyl 2oxopropyl azetidin 2 oneEMI56.1 l,l Carbonyldimidazole .1.10 mmol is added in one portion to a solution of 3S, 4R 1 t butyldimethyl silyl 3 R l hydroxyethyll 4 carboxymethyl azetidin 2 one C1.0 mmol2 in anhydrous tetrahydrofuran 5 ml at room temperature. The resulting solution is stirred at room temperature for 6 hours. In a second flask, magnesium ethoxide 5 mmol is added in one portion to a solution of the mono p nitrobenzyl ester of malonic acid 10 mmol in anhydrous tetrahydrofuran 25 ml .The resulting mixture is stirred at room temperature for 1 hr, then the tetrahydrofuran is removed at the pump and the gummy residue is triturated with ether to yield the magnesium salt as an off white solid. l.l mmol of this magnesium salt is then added to the first reaction flask and the resulting mixture is stirred at room temperature for 18 hrs. The reaction mixture is then poured into 50 ml of ether, washed with 0.5N hydrochloric acid solution 20 ml , water 20 ml , saturated aqueous sodium bicarbonate solution 20 ml , brine and dried over magnesium sulfate. Removal of solvents in vacuo gives an oil which is chromatographed on silica gel ether to yield 3S, 4R 1 t butyldimethylsilyl 3 R 1 hydroxyethyl 4 3 p nitrobenzyloxycarbonyl 2oxopropyl azetidin 2 one. n.m.r. CDCl3 H2O 8.24, 8.10, 7.52, 7.38 2H, AB, aromatic , 5.26 2H, S, CH2 Ar , 3.5 4.2 2H, m, H 5, H 8 , 2.6 3.3 3H, m,H 6, CH2 C , 1.3 3H, d, J 6.6, CH3 0.98 9H, S, Si 0.25 6H, S, CH3 2Si EXAMPLE 27 3S,4R 3 R l hydroxyethyl 4 3 p nitrobenzylOxy carbonyl 2 oxopropyl azetidin 2 oneEMI58.1 A solution of 3S, 4R l t butyldimethylsilyl 3 R l hydroxyethyl 4 3 p nitrobenzyloxyzarbonyl 2 oxopropyl azetidin 2 one 1.0 mmol in 20 ml of 9 1 v v methanol water is cooled to OOC. Concentrated hydrochloric acid 0.34 ml is added and the resulting solution is stirred at OOC for 15 min., then allowed to warm to room temperature. After 2.5 hrs, at room temperature the reaction mixture is diluted with ethyl acetate 25 ml , washed with water 10 ml and. brine, dried over magnesium sulfate and concentrated in vacuo to yield 3S, 4R 3 R l hydroxyethyl 4 .3 p nitrobenzyloxycarbonyl 2 oxopropyl azetidin 2 one.